Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:clinical_trial |
Phase 1
|
| gptkbp:developed_by |
gptkb:Bristol-Myers_Squibb
|
| https://www.w3.org/2000/01/rdf-schema#label |
BMS-986165
|
| gptkbp:indication |
gptkb:disease
gptkb:Oncology |
| gptkbp:mechanism_of_action |
immune checkpoint inhibition
|
| gptkbp:route_of_administration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:structure |
gptkb:Ig_G1
|
| gptkbp:targets |
gptkb:PD-1
|
| gptkbp:type |
gptkb:monoclonal_antibody
|
| gptkbp:used_for |
gptkb:cancer_treatment
|
| gptkbp:bfsParent |
gptkb:DISCOVER-2
|
| gptkbp:bfsLayer |
6
|